CONMED Corp
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
CNMD$51.50-2.5%Stored close · as of Nov 6, 2026
Contents
– Consolidated Condensed Statements of Comprehensive Income for the three and nine months ended , 2025 and 2024
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
| Three Months Ended · Nine Months Ended | ||||
|---|---|---|---|---|
| September 30, | September 30, | |||
| 2025 | 2024 | 2025 | 2024 | |
| Net sales | $337,926 | $316,701 | $1,001,526 | $961,071 |
| Cost of sales | 171,807 | 137,706 | 469,336 | 426,383 |
| Gross profit | 166,119 | 178,995 | 532,190 | 534,688 |
| Selling and administrative expense | 140,339 | 99,730 | 425,207 | 345,611 |
| Research and development expense | 13,901 | 13,558 | 40,985 | 41,250 |
| Operating expenses | 154,240 | 113,288 | 466,192 | 386,861 |
| Income from operations | 11,879 | 65,707 | 65,998 | 147,827 |
| Interest expense | 7,606 | 9,252 | 23,716 | 28,440 |
| Other expense | — | — | 418 | — |
| Income before income taxes | 4,273 | 56,455 | 41,864 | 119,387 |
| Provision for income taxes | 1,414 | 7,471 | 11,548 | 20,719 |
| Net income | $2,859 | $48,984 | $30,316 | $98,668 |
| Comprehensive income | $6,605 | $48,701 | $39,941 | $94,121 |
| Per share data: | ||||
| Net income | ||||
| Basic | $0.09 | $1.59 | $0.98 | $3.20 |
| Diluted | 0.09 | 1.57 | 0.97 | 3.17 |
| Weighted average common shares | ||||
| Basic | 30,955 | 30,856 | 31,027 | 30,815 |
| Diluted | 31,050 | 31,112 | 31,145 | 31,148 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.